Candidates Decry High Drug Prices, But They Have Few Options For Voters

http://khn.org/news/candidates-decry-high-drug-prices-but-they-have-few-options-for-voters/?utm_campaign=KHN%3A+Daily+Health+Policy+Report&utm_source=hs_email&utm_medium=email&utm_content=34504530&_hsenc=p2ANqtz-8jV9oGDFPhUY7AIC7h75jL1KC5hMbGnVXQiBbMw7S-o8a9cNbtaq7e7EyhVHZrYWAX2-Oix7Ha5jcF9E7NZ2gAl0hFHg&_hsmi=34504530

election_voters_drugprices_770

In this year’s presidential campaign, health care has taken a back seat. But one issue appears to be breaking through: the rising cost of prescription drugs.

The blockbuster drugs to treat hepatitis C as well as dramatic price increases on older drugs, most recently the EpiPen allergy treatment, have combined to put the issue back on the front burner.

Democrat Hillary Clinton just issued a lengthy proposal to address what her campaign calls “unjustified price hikes for long-available drugs.” That’s in addition to a broader proposal to address high drug prices the campaign put out last fall.

Republican Donald Trump, meanwhile, has said little about health care since announcing his candidacy in 2015, but he has several times called for a change in law to allowMedicare to negotiate drug prices for the population it serves.

Here are five reasons why this issue is back — and why it is so difficult to solve.

This is how the presidential election is shaping the ongoing drug price debate

This is how the presidential election is shaping the ongoing drug price debate

Change Capsule Pill Filled with Word on Balls

In this year’s presidential campaign, health care has taken a back seat. But one issue appears to be breaking through: the rising cost of prescription drugs.

The blockbuster drugs to treat hepatitis C as well as dramatic price increases on older drugs, most recently the EpiPen allergy treatment, have combined to put the issue back on the front burner.

Democrat Hillary Clinton just issued a lengthy proposal to address what her campaign calls “unjustified price hikes for long-available drugs.” That’s in addition to a broader proposal to address high drug prices the campaign put out last fall.
Republican Donald Trump, meanwhile, has said little about health care since announcing his candidacy in 2015, but he has several times called for a change in law to allow Medicare to negotiate drug prices for the population it serves.

Here are five reasons why this issue is back — and why it is so difficult to solve.

A timeline of eye-popping drug prices

http://www.usatoday.com/story/news/2016/08/25/timeline-eye-popping-drug-prices/89335852/

Image result for epipen

The firestorm over steep price increases for the EpiPen — which can rescue people having life-threatening allergic reactions  — is just the latest in a long line of controversies over high prescription drug prices. A decade ago, much of the concern over prescription drug prices involved new high-tech cancer drugs, used by only a few thousand patients a year. In recent years, the prices for decades-old generic drugs have soared, as well, as pharmaceutical companies purchase the rights for drugs with no competition.

Here’s a recap of some of the most eye-popping prices.

Pfizer’s Involvement in EpiPens Could Complicate Drug Price Debate

https://morningconsult.com/2016/08/26/pfizers-involvement-in-epipens-could-complicate-drug-price-debate/

cnythzl/iStock.com

Mylan Pharmaceuticals has come under intense fire for massive price hikes of EpiPens over the last week, facing scrutiny from lawmakers and industry groups. It is less well known, however, that while Mylan markets and prices the drug, Pfizer Inc. actually manufactures the drug and has seen increased revenues from EpiPens over the last few years.

The financial relationship between the two drug companies is unclear, and Pfizer declined to elaborate. Mylan did not respond to a request for further comment about EpiPens or how the two companies divide revenues.

“Meridian Medical Technologies is the contract manufacturer of EpiPen and takes great pride being able to supply a high quality and life-saving product. The terms of our supply agreement are confidential,” said Rachel Hooper, a Pfizer spokeswoman. Meridian Medical Technologies is a Pfizer subsidiary.

The EpiPen outrage centers around a 400 percent hike for the dispenser, used for emergency allergic reactions, since 2009, even though the product remains unchanged. It now costs as much as $600 for a pack of two EpiPens, which must be replaced every 12 to 18 months.

Election 2016: Big Pharma’s $70 million tops California campaign contributions

http://www.mercurynews.com/health/ci_30117115/election-2016-big-pharmas-70-million-tops-california

With Californians facing the busiest ballot in more than a decade, big spenders are poised to make it one of the most expensive election battles in state history — already contributing $185 million to fight over everything from sex, drugs and guns to tobacco and taxes.

The money is piling up on behalf of campaigns for 17 statewide ballot measures — the most since March 2000. And when it comes to big backers, Big Pharma is far and away the towering force.

According to figures released Monday by the nonprofit MapLight, drug companies have already poured $70 million into an effort to fight Proposition 61, which would limit the prices state agencies pay for prescription drugs.

That’s 38 percent of all the money so far invested into the various ballot measures through July 7, the Berkeley-based group reported. Some observers are predicting drug company contributions will top $100 million by Election Day.

“This is their bread and butter,” said Barbara O’Connor, director emeritus of Sacramento State’s Institute for the Study of Politics and Media, who expects the industry will invest as much money as its needs to win.

https://tpc.googlesyndication.com/safeframe/1-0-4/js/ext.jshttps://tj6w5.flx10.com/libs/launcher-0.1.0.js// <![CDATA[
function whenLoaded(e){“undefined”==typeof Flexitive?setTimeout(function(){whenLoaded(e)},100):e()}function initFlexitive(){(new Flexitive).initialize({creativeId:”1pEL2SliaiX”,creativeHost:”tj6w5.flx10.com”,creativeProtocol:”https”,displayType:”in-page”,targetId:targetId,breakpoint:”300×250″,cacheBuster:”1899094989″,clickTrackerUnEsc:”http://adclick.g.doubleclick.net/pcs/click?xai=AKAOjst65akkmyBthE69yzRl37h-WqfsSlEyRZEBAy8xbiuRN1z_a_kQg3l05B2SwJOdl2dFniW7CRLglqSmrU76CPawcNvgzaIkFxcbx_xdNrCgW_G6sanHcNhp7A6fcCabmLe2bdeavXKMQKsfQfUHAEZRzGGOi0JLj0H09N2xA3l03eiErjQACMGmWbiprvEUrJL4nIh9MDJmXwnfZr5ORnA342jKJHo2CffvLHANayS0XoWfG0PxWc3IvFf1gqZhvyaE2tiSFGgt&sig=Cg0ArKJSzKS6d2QjhAUJEAE&urlfix=1&adurl=&#8221;,destUrlUnEsc:”http://www.recyclesmart.org/foodscraps&#8221;})}var targetId=”flexitive_”+1e18*Math.random();document.write(‘

‘),whenLoaded(initFlexitive);
// ]]>// <![CDATA[
(function(){var k=this,aa=function(a){var b=typeof a;if(“object”==b)if(a){if(a instanceof Array)return”array”;if(a instanceof Object)return b;var c=Object.prototype.toString.call(a);if(“[object Window]”==c)return”object”;if(“[object Array]”==c||”number”==typeof a.length&&”undefined”!=typeof a.splice&&”undefined”!=typeof a.propertyIsEnumerable&&!a.propertyIsEnumerable(“splice”))return”array”;if(“[object Function]”==c||”undefined”!=typeof a.call&&”undefined”!=typeof a.propertyIsEnumerable&&!a.propertyIsEnumerable(“call”))return”function”}else return”null”;else if(“function”==b&&”undefined”==typeof a.call)return”object”;return b},l=function(a){return”string”==typeof a},ba=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var b=c.slice();b.push.apply(b,arguments);return a.apply(this,b)}},q=Date.now||function(){return+new Date},r=function(a,b){var c=a.split(“.”),d=k;c[0]in d||!d.execScript||d.execScript(“var “+c[0]);for(var e;c.length&&(e=c.shift());)c.length||void 0===b?d=d[e]?d[e]:d[e]={}:d[e]=b};var ca=function(a,b,c,d,e){if(e)c=a+(“&”+b+”=”+c);else{var f=”&”+b+”=”,g=a.indexOf(f);0>g?c=a+f+c:(g+=f.length,f=a.indexOf(“&”,g),c=0<=f?a.substring(0,g)+c+a.substring(f):a.substring(0,g)+c)}return 2E3<c.length?void 0!="=d?ca(a,b,d,void" 0,e):a:c};var="" da="function(){var" a="/[&\?#]exk=([^&" ]+)="" .exec(u.location.href);return="" a&&2="=a.length?a[1]:null};var" ea="String.prototype.trim?function(a){return" a.trim()}:function(a){return="" a.replace(="" ^[\s\xa0]+|[\s\xa0]+$="" g,"")},ga="function(a,b){for(var" c="0,d=ea(String(a)).split("."),e=ea(String(b)).split("."),f=Math.max(d.length,e.length),g=0;0==c&&g<f;g++){var" h="d[g]||"",m=e[g]||"",n=RegExp("(\\d*)(\\D*)","g"),p=RegExp("(\\d*)(\\D*)","g");do{var" v="n.exec(h)||["","",""],t=p.exec(m)||["","",""];if(0==v[0].length&&0==t[0].length)break;c=fa(0==v[1].length?0:parseInt(v[1],10),0==t[1].length?0:parseInt(t[1],10))||fa(0==v[2].length,0==t[2].length)||fa(v[2],t[2])}while(0==c)}return" c},fa="function(a,b){return" ab?1:0};var ha=function(a,b,c){if(“array”==aa(b))for(var d=0;d<b.length;d++)ha(a,string(b[d]),c);else null!="b&&c.push("&",a,""===b?"":"=",encodeURIComponent(String(b)))},ia=function(a,b,c){for(c=c||0;c<b.length;c+=2)ha(b[c],b[c+1],a);return" a},ja="function(a,b){var" c="2==arguments.length?ia([a],arguments[1],0):ia([a],arguments,1);if(c[1]){var" d="c[0],e=d.indexOf("#");0e?c[1]=”?”:e==d.length-1&&(c[1]=void 0)}return c.join(“”)};var ka=Array.prototype.indexOf?function(a,b,c){return Array.prototype.indexOf.call(a,b,c)}:function(a,b,c){c=null==c?0:0>c?Math.max(0,a.length+c):c;if(l(a))return l(b)&&1==b.length?a.indexOf(b,c):-1;for(;c<a.length;c++)if(c in="" a&&a[c]="==b)return" c;return-1},la="Array.prototype.forEach?function(a,b,c){Array.prototype.forEach.call(a,b,c)}:function(a,b,c){for(var" d="a.length,e=l(a)?a.split(""):a,f=0;f<d;f++)f" e&&b.call(c,e[f],f,a)},ma="Array.prototype.map?function(a,b,c){return" array.prototype.map.call(a,b,c)}:function(a,b,c){for(var="" f&&(e[g]="b.call(c,f[g],g,a));return" e};var="" na="function(a,b){for(var" c="" a)b.call(void="" 0,a[c],c,a)},oa="function(a,b){return" null!="=a&&b" a};var="" w;a:{var="" pa="k.navigator;if(pa){var" qa="pa.userAgent;if(qa){w=qa;break" a}}w="""}var" x="function(a){return-1!=w.indexOf(a)},ua=function(a){for(var" b="RegExp("(\\w[\\w" ]+)="" ([^\\s]+)\\s*(?:\\((.*?)\\))?","g"),c="[],d;d=b.exec(a);)c.push([d[1],d[2],d[3]||void" 0]);return="" c};var="" va="function(){return" x("trident")||x("msie")},y="function(){return(x("Chrome")||x("CriOS"))&&!x("Edge")},xa=function(){function" a(a){var="" b;a:{b="d;for(var" g="a.length,h=l(a)?a.split(""):a,m=0;mb?null:l(a)?a.charAt(b):a[b]]||””}var b=w;if(va())return wa(b);var b=ua(b),c={};la(b,function(a){c[a[0]]=a[1]});var d=ba(oa,c);return x(“Opera”)?a([“Version”,”Opera”]):x(“Edge”)?a([“Edge”]):y()?a([“Chrome”,”CriOS”]):(b=b[2])&&b[1]||””},wa=function(a){var b=/rv: *([\d\.]*)/.exec(a);if(b&&b[1])return b[1];var b=””,c=/MSIE +([\d\.]+)/.exec(a);if(c&&c[1])if(a=/Trident\/(\d.\d)/.exec(a),”7.0″==c[1])if(a&&a[1])switch(a[1]){case “4.0”:b=”8.0″;break;case “5.0”:b=”9.0″;break;case “6.0”:b=”10.0″;break;case “7.0”:b=”11.0″}else b=”7.0″;else b=c[1];return b};var ya=function(a){ya[” “](a);return a};ya[” “]=function(){};var za=function(a,b){for(var c in a)Object.prototype.hasOwnProperty.call(a,c)&&b.call(void 0,a[c],c,a)},Ba=function(){var a=Aa;if(!a)return””;var b=/.*[&#?]google_debug(=[^&]*)?(&.*)?$/;try{var c=b.exec(decodeURIComponent(a));if(c)return c[1]&&1e)return””;a.c.sort(function(a,b){return a-b});d=null;c=””;for(var f=0;f<a.c.length;f++)for(var g="a.c[f],h=a.f[g],m=0;m=n.length){e-=n.length;b+=n;c=a.g;break}else a.l&&(c=e,n[c-1]==a.g&&–c,b+=n.substr(0,c),c=a.g,e=0);d=null==d?g:d}}f=””;a.h&&null!=d&&(f=c+a.h+”=”+(a.P||d));return b+f+””},Ha=function(a){if(!a.h)return a.o;var b=1,c;for(c in a.f)b=c.length>b?c.length:b;return a.o-a.h.length-b-a.g.length-1},Ia=function(a,b,c,d,e){var f=[];za(a,function(a,h){var m=Ka(a,b,c,d,e);m&&f.push(h+”=”+m)});return f.join(b)},Ka=function(a,b,c,d,e){if(null==a)return””;b=b||”&”;c=c||”,$”;”string”==typeof c&&(c=c.split(“”));if(a instanceof Array){if(d=d||0,d<c.length){for(var f="[],g=0;ge?encodeURIComponent(Ia(a,b,c,d,e+1)):”…”;return encodeURIComponent(String(a))};var La=function(a,b,c,d,e){try{var f;c instanceof Fa?f=c:(f=new Fa,za(c,function(a,b){var c=f,d=c.L++,e=Ga(b,a);c.c.push(d);c.f[d]=e}));if((d?a.O:Math.random())<(e||a.H)){var g=Ja(f,a.N,a.I,a.M+b+”&”);A(k,g)}}catch(h){}},A=function(a,b,c){a.google_image_requests||(a.google_image_requests=[]);var d=a.document.createElement(“img”);if(c){var e=function(a){c(a);a=e;d.removeEventListener?d.removeEventListener(“load”,a,!1):d.detachEvent&&d.detachEvent(“onload”,a);a=e;d.removeEventListener?d.removeEventListener(“error”,a,!1):d.detachEvent&&d.detachEvent(“onerror”,a)};Ea(d,”load”,e);Ea(d,”error”,e)}d.src=b;a.google_image_requests.push(d)};var Ma=function(a,b,c){this.u=a;this.K=b;this.i=c;this.j=null;this.J=this.s;this.A=!1},Na=function(a,b,c){this.message=a;this.fileName=b||””;this.lineNumber=c||-1},Pa=function(a,b,c){var d;try{d=c()}catch(g){var e=a.i;try{var f=Oa(g),e=a.J.call(a,b,f,void 0,void 0)}catch(h){a.s(“pAR”,h)}if(!e)throw g;}finally{}return d},B=function(a,b){var c=Qa;return function(){for(var d=[],e=0;e<arguments.length;++e)d[e]=arguments[e];return pa(c,a,function(){return="" b.apply(void="" 0,d)})}};ma.prototype.s="function(a,b,c,d,e){try{var" f="e||this.K,g=new" fa;g.l="!0;z(g,1,"context",a);b" instanceof="" na||(b="Oa(b));z(g,2,"msg",b.message.substring(0,512));b.fileName&&z(g,3,"file",b.fileName);0<b.lineNumber&&z(g,4,"line",b.lineNumber.toString());b={};if(this.j)try{this.j(b)}catch(I){}if(d)try{d(b)}catch(I){}d=[b];g.c.push(5);g.f[5]=d;var" h;e="k;d=[];var" m,n="null;do{b=e;var" p;try{var="" v;if(v="!!b&&null!=b.location.href)b:{try{ya(b.foo);v=!0;break" b}catch(i){}v="!1}p=v}catch(I){p=!1}p?(m=b.location.href,n=b.document&&b.document.referrer||null):(m=n,n=null);d.push(new" da(m||""));try{e="b.parent}catch(I){e=null}}while(e&&b!=e);m=0;for(var" t="d.length-1;m<=t;++m)d[m].depth=t-m;b=k;if(b.location&&b.location.ancestorOrigins&&b.location.ancestorOrigins.length==d.length-1)for(m=1;m<d.length;++m){var" ra="d[m];ra.url||(ra.url=b.location.ancestorOrigins[m-1]||"",ra.m=!0)}for(var" sa="new" da(k.location.href,!1),ta="d.length-1,t=ta;0parseFloat(Ya)){Xa=String($a);break a}}Xa=Ya}var ab=Xa,bb={},E=function(a){return bb[a]||(bb[a]=0<=ga(ab,a))},cb=k.document,db=cb&&C?Wa()||(“CSS1Compat”==cb.compatMode?parseInt(ab,10):5):void 0;var F=function(a,b){this.width=a;this.height=b};F.prototype.clone=function(){return new F(this.width,this.height)};F.prototype.ceil=function(){this.width=Math.ceil(this.width);this.height=Math.ceil(this.height);return this};F.prototype.floor=function(){this.width=Math.floor(this.width);this.height=Math.floor(this.height);return this};F.prototype.round=function(){this.width=Math.round(this.width);this.height=Math.round(this.height);return this};F.prototype.scale=function(a,b){this.width*=a;this.height*=”number”==typeof b?b:a;return this};!D&&!C||C&&9<=Number(db)||D&&E(“1.9.1”);C&&E(“9”);var G=document,u=window;var H=null,eb=function(){if(!G.body)return!1;if(!H){var a=G.createElement(“iframe”);a.style.display=”none”;a.id=”anonIframe”;H=a;G.body.appendChild(a)}return!0};var Qa;Qa=new Ma(new function(){this.N=”http:”===u.location.protocol?”http:”:”https:”;this.I=”pagead2.googlesyndication.com”;this.M=”/pagead/gen_204?id=”;this.H=.01;this.O=Math.random()},”jserror”,!0);var K=function(a,b){return B(a,b)};C&&E(“9”);!Va||E(“528”);D&&E(“1.9b”)||C&&E(“8”)||Ta&&E(“9.5”)||Va&&E(“528”);D&&!E(“8”)||C&&E(“9″);var fb=0,L={},hb=function(a){var b=L.imageLoadingEnabled;if(null!=b)a(b);else{var c=!1;gb(function(b,e){delete L[e];c||(c=!0,null!=L.imageLoadingEnabled||(L.imageLoadingEnabled=b),a(b))})}},gb=function(a){var b=new Image,c,d=””+fb++;L[d]=b;b.onload=function(){clearTimeout(c);a(!0,d)};c=setTimeout(function(){a(!1,d)},300);b.src=”data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==”},ib=function(a){if(a){var b=document.createElement(“OBJECT”);b.data=a;b.width=1;b.height=1;b.style.visibility=”hidden”;var c=””+fb++;L[c]=b;b.onload=b.onerror=function(){delete L[c]};document.body.appendChild(b)}},jb=function(a){if(a){var b=new Image,c=””+fb++;L[c]=b;b.onload=b.onerror=function(){delete L[c]};b.src=a}},kb=function(a){a&&hb(function(b){b?jb(a):ib(a)})};var lb={F:”ud=1″,D:”ts=0″,T:”sc=1″,B:”gz=1″,C:”op=1″,U:”efp=1″,S:”rda=1″,R:”dcl=1″};if(G&&G.URL){var Aa=G.URL,mb=!(Aa&&0=b)){var d=0,e=function(){a();d++;db;){try{if(c.google_osd_static_frame)return c}catch(e){}try{if(c.aswift_0&&(!a||c.aswift_0.google_osd_static_frame))return c.aswift_0}catch(e){}b++;c=c!=c.parent?c.parent:null}return null},tb=function(a,b,c,d,e){if(10<rb)u.clearinterval(qb);else if(++rb,u.postmessage&&(b.b||b.a)){var="" f="sb(!0);if(f){var" g="{};O(b,g);g[0]="goog_request_monitoring";g[6]=a;g[16]=c;d&&d.length&&(g[17]=d.join(","));e&&(g[19]=e);try{var" h="pb(g);f.postMessage(h,"*")}catch(m){}}}},ub=function(a){var" b="sb(!1),c=!b;!b&&u&&(b=u.parent);if(b&&b.postMessage)try{b.postMessage(a,"*"),c&&u.postMessage(a,"*")}catch(d){}};var" q="!1,vb=function(a){if(a=a.match(/[\d]+/g))a.length=3};(function(){if(navigator.plugins&&navigator.plugins.length){var" a="navigator.plugins["Shockwave" flash"];if(a&&(q="!0,a.description)){vb(a.description);return}if(navigator.plugins["Shockwave" flash="" 2.0"]){q="!0;return}}if(navigator.mimeTypes&&navigator.mimeTypes.length&&(a=navigator.mimeTypes["application/x-shockwave-flash"],Q=!(!a||!a.enabledPlugin))){vb(a.enabledPlugin.description);return}try{var" activexobject("shockwaveflash.shockwaveflash.7");q="!0;vb(b.GetVariable("$version"));return}catch(c){}try{b=new" activexobject("shockwaveflash.shockwaveflash.6");q="!0;return}catch(c){}try{b=new" activexobject("shockwaveflash.shockwaveflash"),q="!0,vb(b.GetVariable("$version"))}catch(c){}})();var" wb="x("Firefox"),xb=Sa()||x("iPod"),yb=x("iPad"),zb=x("Android")&&!(y()||x("Firefox")||x("Opera")||x("Silk")),Ab=y(),Bb=x("Safari")&&!(y()||x("Coast")||x("Opera")||x("Edge")||x("Silk")||x("Android"))&&!(Sa()||x("iPad")||x("iPod"));var" r="function(a){return(a=a.exec(w))?a[1]:""};(function(){if(wb)return" r(="" firefox\="" ([0-9.]+)="" );if(c||ua||ta)return="" ab;if(ab)return="" chrome\="" );if(bb&&!(sa()||x("ipad")||x("ipod")))return="" version\="" );if(xb||yb){var="" a[1]+"."+a[2]}else="" if(zb)return(a="R(/Android\s+([0-9.]+)/))?a:R(/Version\/([0-9.]+)/);return""})();var" db="function(){var" c;a="u||u;try{var" d;if(a.document&&!a.document.body)d="new" f(-1,-1);else{var="" e="(a||window).document,f="CSS1Compat"==e.compatMode?e.documentElement:e.body;d=(new" f(f.clientwidth,f.clientheight)).round()}c="d}catch(g){c=new" f(-12245933,-12245933)}return="" cb(c)}c="(u.document||document).getElementsByTagName("SCRIPT");return" 0<c.length&&(c="c[c.length-1],c.parentElement&&c.parentElement.id&&0<c.parentElement.id.indexOf("_ad_container"))?Cb(void" 0,c.parentelement):null},cb="function(a,b){var" c="Eb("IMG",a,b);return" c||(c="Eb("IFRAME",a,b))?c:(c=Eb("OBJECT",a,b))?c:null},Eb=function(a,b,c){var" d="document;c=c||d;d=a&&"*"!=a?a.toUpperCase():"";c=c.querySelectorAll&&c.querySelector&&d?c.querySelectorAll(d+""):c.getElementsByTagName(d||"*");for(d=0;d<c.length;d++){var" a}}}f="e.clientHeight;g=e.clientWidth;if(h=b)h=new" f(g,f),h="Math.abs(b.width-h.width)<.1*b.width&&Math.abs(b.height-h.height)<.1*b.height;if(h||!b&&10<f&&10<g)return" e}return="" null};var="" s="0,Fb="",Gb=[],T=!1,U=!1,V=!1,Hb=!0,Ib=!1,Jb=!1,Kb=!1,Lb=!1,Mb=!1,Nb=!1,Ob=0,Pb=0,W=0,Qb=[],P=null,Rb="",Sb=[],Tb=null,Ub=[],Vb=!1,Xb="",Yb="",Zb=(new" date).gettime(),$b="!1,ac="",bc=!1,cc=["1","0","3"],X=0,Y=0,dc=0,ec="",gc=function(a,b,c){T&&(Hb||3!=(c||3)||Kb)&&fc(a,b,!0);if(V||U&&Jb)fc(a,b),U=V=!1},hc=function(){var" a?2!="a():!0},fc=function(a,b,c){if((b=b||Rb)&&!Vb&&(2==Y||c)&&hc()){for(var" 0)}mb="!0;c?T=!1:Vb=!0}},jc=function(a,b){var" c.length?"="" pagead2.googlesyndication.com="" activeview?"+c.join("&"):"="" activeview"},ic="function(a,b,c){c=c?"osdim":V?"osd2":"osdtos";a=[a,-1<a.indexOf("?")?"&id=":"?id=",c];"osd2"==c&&U&&Jb&&a.push("&ts=1");a.push("&ti=1");a.push("&",b);a.push("&uc="+dc);$b?a.push("&tgt="+ac):a.push("&tgt=nf");a.push("&cl="+(bc?1:0));Nb&&(a.push("&lop=1"),b=q()-Ob,a.push("&tslp="+b));b=a.join("");for(a=0;a<Sb.length;a++){try{var" b},z="function(a){if(Xb){try{var" 0)}catch(c){}0=e)){var f=Number(c[d].substr(0,e)),e=c[d].substr(e+1);switch(f){case 5:case 8:case 11:case 15:case 16:case 18:e=”true”==e;break;case 4:case 7:case 6:case 14:case 20:case 21:case 22:case 23:case 24:e=Number(e);break;case 3:case 19:if(“function”==aa(decodeURIComponent))try{e=decodeURIComponent(e)}catch(h){throw Error(“Error: URI malformed: “+e);}break;case 17:e=ma(decodeURIComponent(e).split(“,”),Number)}b[f]=e}}b=b[0]?b:null}else b=null;if(b&&(c=new N(b[4],b[12]),P&&P.match(c))){for(c=0;cX&&!U&&2==Y&&nc(u,”osd2″,”hs=”+X)},pc=function(){var a={};O(P,a);a[0]=”goog_dom_content_loaded”;var b=pb(a);try{nb(function(){ub(b)},10,”osd_listener::ldcl_int”)}catch(c){}},qc=function(){var a={};O(P,a);a[0]=”goog_creative_loaded”;var b=pb(a);nb(function(){ub(b)},10,”osd_listener::lcel_int”);bc=!0},rc=function(a){if(l(a)){a=a.split(“&”);for(var b=a.length-1;0<=b;b–){var c=a[b],d=lb;c==d.F?(Hb=!1,a.splice(b,1)):c==d.B?(W=1,a.splice(b,1)):c==d.D?(U=!1,a.splice(b,1)):c==d.C&&(Ib=!0,a.splice(b,1))}ec=a.join(“&”)}},sc=function(){if(!$b){var a=Db();a&&($b=!0,ac=a.tagName,a.complete||a.naturalWidth?qc():M(a,”load”,qc,”osd_listener::creative_load”))}};r(“osdlfm”,K(“osd_listener::init”,function(a,b,c,d,e,f,g,h,m,n){S=a;Xb=b;Yb=d;T=f;g&&rc(g);U=f;1==h?Qb.push(947190538):2==h?Qb.push(947190541):3==h&&Qb.push(947190542);P=new N(e,da());M(u,”load”,kc,”osd_listener::load”);M(u,”message”,mc,”osd_listener::message”);Fb=c||””;Gb=[n||jc(c,m)];M(u,”unload”,oc,”osd_listener::unload”);var p=u.document;!p.readyState||”complete”!=p.readyState&&”loaded”!=p.readyState?!va()||0<=ga(xa(),11)?M(p,”DOMContentLoaded”,pc,”osd_listener::dcl”):M(p,”readystatechange”,function(){“complete”!=p.readyState&&”loaded”!=p.readyState||pc()},”osd_listener::rsc”):pc();-1==S?Y=f?3:1:-2==S?Y=3:0
// ]]>// http://js.moatads.com/bangdfp107159576598/moatad.js#moatClientLevel1=299717054&moatClientLevel2=509171534&moatClientLevel3=532396214&moatClientLevel4=101435122814&moatClientSlicer1=24253214&moatClientSlicer2=78060854&zMoatPS=Cube_Article&zMoatST=

The beneficiary of that drug company money, Californians Against the Misleading Rx Measure, says they got an early start on raising campaign cash. “As the other campaigns start kicking into high gear, they will start raising more,” said Kathy Fairbanks, the no campaign’s spokeswoman.

The AIDS Healthcare Foundation, the measure’s sponsor, has raised about $10 million, according to president Michael Weinstein.

“Maybe $100 million can convince people to vote against what is in their own best interest,” said Weinstein. “From our point of view, today, tomorrow or 10 years from now, justice will prevail on drug pricing.”

With tens of millions on hand, drug makers fight state efforts to force down prices

With tens of millions on hand, drug makers fight state efforts to force down prices

Drug makers are sick and tired of coming under attack for high prices.

And they’re spending tens of millions to try to make it stop.

“We’re under unprecedented pressure because there really is profound misunderstanding out there,” Acorda Therapeutics CEO Ron Cohen, who chairs the industry trade group Biotechnology Innovation Organization, told a crowd at BIO’s conference here this week.

“Together we’re going to fight back, and we’re going to win,” Jim Greenwood, the CEO of BIO, said in his keynote address.

Bills that would have required drug companies to justify, explain, or even cap their prices have faltered in about a dozen states in recent months. Last week, however, brought two blows to the industry: Vermont Governor Peter Shumlin Drug signed into law a transparency act that requires drug makers to justify price hikes. Similar legislation passed in the California state Senate.

Meanwhile, the industry is girding for another California fight this November over a ballot measure that seeks to cap some drug prices. A similar measure is in the works in Ohio. And the industry fears such ballot measures could pop up elsewhere.

But drug makers aren’t responding by cutting prices  — or even by keeping them stable.

 

CA Drug Price Relief Act Begins Campaign with 73% Support

http://www.yeson61.com/statewide-poll-shows-strong-support-proposition-61/

STATEWIDE POLL SHOWS STRONG SUPPORT FOR PROPOSITION 61

Yes on Prop 61/Californians for Lower Drug Prices today released the results of a statewide survey that demonstrates strong, across-the-board support for Proposition 61, The California Drug Price Relief Act, a measure to reduce drug prices paid by the State of California.

“We’re pleased that California voters have expressed such strong support for this initiative to cap drug prices,” said Garry South, lead strategist for the Yes on Prop. 61 campaign. “We don’t underestimate the effect of Big Pharma’s $100-million campaign of lies, distortions and self-serving misstatements about Prop. 61, but we start off in a very strong position. We’ll see if voters get as sick and tired of the Pharma ads against 61 as they are of the omnipresent drug-pushing ads that dominate the TV screen.”

Tulchin Research conducted the statewide survey on behalf of Yes on Proposition 61 to assess the prospects of the statewide ballot measure to help reduce the state’s prescription drug costs by requiring the state to purchase drugs from drug companies at the lowest price those companies charge the federal government. The results reveal strong bipartisan support for the measure across the state. The survey finds that nearly three-quarters of voters would vote yes in support of Proposition 61 (73% yes with leaners, 66% without leaners).